Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New York Inspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain’.
The above information is a part of company’s filings submitted to BSE.